IAPP in type II diabetes: Basic research on structure, molecular interactions, and disease mechanisms suggests potential intervention strategies.

Islet amyloid polypeptide (a.k.a. IAPP, amylin) is a 37 amino acid hormone that has long been associated with the progression of type II diabetes mellitus (TIIDM) disease. The endocrine peptide hormone aggregatively misfolds to form amyloid deposits in and around the pancreatic islet β-cells that synthesize both insulin and IAPP, leading to a decrease in β-cell mass in patients with the disease. Extracellular IAPP amyloids induce β-cell death through the formation of reactive oxygen species, mitochondrial dysfunction, chromatin condensation, and apoptotic mechanisms, although the precise roles of IAPP in TIIDM are yet to be established. Here we review aspects of the normal physiological function of IAPP in glucose regulation together with insulin, and its misfolding which contributes to TIIDM, and may also play roles in other pathologies such as Alzheimer's and heart disease. We summarize information on expression of the IAPP gene, the regulation of the hormone by post-translational modifications, the structural properties of the peptide in various states, the kinetics of misfolding to amyloid fibrils, and the interactions of the peptide with insulin, membranes, glycosaminoglycans, and nanoparticles. Finally, we describe how basic research is starting to have a positive impact on the development of approaches to circumvent IAPP amyloidogenesis. These include therapeutic strategies aimed at stabilizing non-amyloidogenic states, inhibition of amyloid growth or disruption of amyloid fibrils, antibodies directed towards amyloid structures, and inhibition of interactions with cofactors that facilitate aggregation or stabilize amyloids.

• Publication year

  2018

• Venue

  Biochimica et Biophysica Acta - Biomembranes

• Publication date

  2018-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bbamem.2018.02.020PMID 29518374
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Islet Amyloid Polypeptide Membrane Interactions: Effects of Membrane Composition.

  2017cited by this paper
• Structural Studies of Amyloid Proteins at the Molecular Level.

  2017cited by this paper
• The redox environment triggers conformational changes and aggregation of hIAPP in Type II Diabetes

  2017cited by this paper
• Islet amyloid polypeptide: Another key molecule in Alzheimer’s pathogenesis?

  2017cited by this paper
• Stabilization and structural analysis of a membrane-associated hIAPP aggregation intermediate

  2017cited by this paper
• Key aromatic/hydrophobic amino acids controlling a cross-amyloid peptide interaction versus amyloid self-assembly

  2017cited by this paper
• Differential effects of silver and iron oxide nanoparticles on IAPP amyloid aggregation.

  2017cited by this paper
• Induction of IAPP amyloid deposition and associated diabetic abnormalities by a prion-like mechanism

  2017cited by this paper
• Living Cell Microarrays: An Overview of Concepts

  2016cited by this paper
• Inhibition of Insulin Amyloid Fibrillation by a Novel Amphipathic Heptapeptide

  2016cited by this paper
• Foldamer-mediated manipulation of a pre-amyloid toxin

  2016cited by this paper
• Stabilizing Off-pathway Oligomers by Polyphenol Nanoassemblies for IAPP Aggregation Inhibition

  2016cited by this paper
• Graphene oxide inhibits hIAPP amyloid fibrillation and toxicity in insulin-producing NIT-1 cells.

  2016cited by this paper
• ABCA1 deficiency and cellular cholesterol accumulation increases islet amyloidogenesis in mice

  2016cited by this paper
• Inhibition of hIAPP Amyloid Aggregation and Pancreatic β-Cell Toxicity by OH-Terminated PAMAM Dendrimer.

  2016cited by this paper
• The Role of Cholesterol in Driving IAPP-Membrane Interactions.

  2016cited by this paper
• Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics

  2016cited by this paper
• Quenched Hydrogen Exchange NMR of Amyloid Fibrils.

  2016cited by this paper
• Human Islet Amyloid Polypeptide N-Terminus Fragment Self-Assembly: Effect of Conserved Disulfide Bond on Aggregation Propensity

  2016cited by this paper
• Abstract 14408: Hyperamylinemia Increases IL-1β Synthesis in the Heart via Peroxidative Sarcolemmal Injury

  2016cited by this paper
• Amyloid Formation in Human Islets Is Enhanced by Heparin and Inhibited by Heparinase

  2015cited by this paper
• Design and Optimization of Anti-amyloid Domain Antibodies Specific for β-Amyloid and Islet Amyloid Polypeptide*

  2015cited by this paper
• Islet amyloid polypeptide exerts a novel autocrine action in β‐cell signaling and proliferation

  2015cited by this paper
• Charge-Based Inhibitors of Amylin Fibrillization and Toxicity

  2015cited by this paper
• Effects of gold complexes on the assembly behavior of human islet amyloid polypeptide.

  2015cited by this paper
• Role of Cholesterol and Phospholipids in Amylin Misfolding, Aggregation and Etiology of Islet Amyloidosis.

  2015cited by this paper
• Complete characterization of the mutation landscape reveals the effect on amylin stability and amyloidogenicity

  2015cited by this paper
• Inhibition of IAPP aggregation by insulin depends on the insulin oligomeric state regulated by zinc ion concentration

  2015cited by this paper
• Inhibition of Toxic IAPP Amyloid by Extracts of Common Fruits.

  2015cited by this paper
• Promotion or Inhibition of Islet Amyloid Polypeptide Aggregation by Zinc Coordination Depends on Its Relative Concentration.

  2015cited by this paper
• Effects of N-glycosylation on protein conformation and dynamics: Protein Data Bank analysis and molecular dynamics simulation study

  2015cited by this paper
• Heparan Sulfate Proteoglycans Are Important for Islet Amyloid Formation and Islet Amyloid Polypeptide-induced Apoptosis*

  2015cited by this paper
• Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component.

  2015cited by this paper
• Structure‐Making Effects of Metal Nanoparticles in Amyloid Peptide Fibrillation

  2015cited by this paper
• Nanoscale Heterogeneity of the Molecular Structure of Individual hIAPP Amyloid Fibrils Revealed with Tip-Enhanced Raman Spectroscopy.

  2015cited by this paper
• Analysis of the ability of pramlintide to inhibit amyloid formation by human islet amyloid polypeptide reveals a balance between optimal recognition and reduced amyloidogenicity.

  2015cited by this paper
• Exploring the Influence of EGCG on the β-Sheet-Rich Oligomers of Human Islet Amyloid Polypeptide (hIAPP1–37) and Identifying Its Possible Binding Sites from Molecular Dynamics Simulation

  2014cited by this paper
• Inhibition of islet amyloid polypeptide fibril formation by selenium-containing phycocyanin and prevention of beta cell apoptosis.

  2014cited by this paper
• Amyloid-based nanosensors and nanodevices.

  2014cited by this paper
• Thioredoxin-interacting Protein Promotes Islet Amyloid Polypeptide Expression through miR-124a and FoxA2*

  2014cited by this paper
• Peptide Amyloid Surface Display

  2014cited by this paper
• Amylin activates distributed CNS nuclei to control energy balance.

  2014cited by this paper
• Cardioprotection by Controlling Hyperamylinemia in a “Humanized” Diabetic Rat Model

  2014cited by this paper
• Classification of Intrinsically Disordered Regions and Proteins

  2014cited by this paper
• A hIAPP‐derived all‐d‐amino‐acid inhibits hIAPP fibrillation efficiently at membrane surface by targeting α‐helical oligomeric intermediates

  2014cited by this paper
• The amyloid state and its association with protein misfolding diseases

  2014cited by this paper
• pH dependence of amylin fibrillization.

  2014cited by this paper
• Mutational Analysis of the Ability of Resveratrol To Inhibit Amyloid Formation by Islet Amyloid Polypeptide: Critical Evaluation of the Importance of Aromatic–Inhibitor and Histidine–Inhibitor Interactions

  2014cited by this paper
• Synthesis of 2,5-diaryl-substituted thiophenes as helical mimetics: towards the modulation of islet amyloid polypeptide (IAPP) amyloid fibril formation and cytotoxicity.

  2014cited by this paper
• Exploring the Influence of Carbon Nanoparticles on the Formation of β-Sheet-Rich Oligomers of IAPP22–28 Peptide by Molecular Dynamics Simulation

  2013cited by this paper
• Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils.

  2013cited by this paper
• Amide Proton Solvent Protection in Amylin Fibrils Probed by Quenched Hydrogen Exchange NMR

  2013cited by this paper
• Mechanism of IAPP amyloid fibril formation involves an intermediate with a transient β-sheet

  2013cited by this paper
• The interaction of amylin with other hormones in the control of eating

  2013cited by this paper
• Cations as switches of amyloid-mediated membrane disruption mechanisms: calcium and IAPP.

  2013cited by this paper
• Acidic pH retards the fibrillization of human Islet Amyloid Polypeptide due to electrostatic repulsion of histidines.

  2013cited by this paper
• Amylin deposition in the brain: A second amyloid in Alzheimer disease?

  2013cited by this paper
• Structural Similarities and Differences between Amyloidogenic and Non-Amyloidogenic Islet Amyloid Polypeptide (IAPP) Sequences and Implications for the Dual Physiological and Pathological Activities of These Peptides

  2013cited by this paper
• A foldamer approach to targeting membrane bound helical states of islet amyloid polypeptide.

  2013cited by this paper
• Islet amyloid polypeptide toxicity and membrane interactions

  2013cited by this paper
• Glycosylation of pramlintide: synthetic glycopeptides that display in vitro and in vivo activities as amylin receptor agonists.

  2013cited by this paper
• Proanthocyanidins are the major anti-diabetic components of cinnamon water extract.

  2013cited by this paper
• Salvianolic acid B inhibits the amyloid formation of human islet amyloid polypeptideand protects pancreatic beta‐cells against cytotoxicity

  2013cited by this paper
• Mechanisms of islet amyloidosis toxicity in type 2 diabetes

  2013cited by this paper
• Morin hydrate inhibits amyloid formation by islet amyloid polypeptide and disaggregates amyloid fibers

  2012cited by this paper
• Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols.

  2012cited by this paper
• Sensitivity of amyloid formation by human islet amyloid polypeptide to mutations at residue 20.

  2012cited by this paper
• Curcumin modulates the self-assembly of the islet amyloid polypeptide by disassembling α-helix.

  2012cited by this paper
• Cross-amyloid interaction of Aβ and IAPP at lipid membranes.

  2012cited by this paper
• Hyperamylinemia Contributes to Cardiac Dysfunction in Obesity and Diabetes: A Study in Humans and Rats

  2012cited by this paper
• A Generic Crystallization-like Model That Describes the Kinetics of Amyloid Fibril Formation*♦

  2012cited by this paper
• The polyphenol EGCG inhibits amyloid formation less efficiently at phospholipid interfaces than in bulk solution.

  2012cited by this paper
• Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective.

  2012cited by this paper
• Concentration‐dependent transitions govern the subcellular localization of islet amyloid polypeptide

  2012cited by this paper
• Glycosaminoglycans (GAGs) suppress the toxicity of HypF-N prefibrillar aggregates.

  2012cited by this paper
• Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective.

  2012cited by this paper
• Metabolic stress, IAPP and islet amyloid

  2012cited by this paper
• Conformations of Islet Amyloid Polypeptide Monomers in a Membrane Environment: Implications for Fibril Formation

  2012cited by this paper
• Inhibition of semen-derived enhancer of virus infection (SEVI) fibrillogenesis by zinc and copper

  2012cited by this paper
• Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment.

  2011cited by this paper
• Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets

  2011cited by this paper
• Inhibition of glycosaminoglycan-mediated amyloid formation by islet amyloid polypeptide and proIAPP processing intermediates.

  2011cited by this paper
• Intrinsically disordered proteins from A to Z.

  2011cited by this paper
• MCP-1 Upregulates Amylin Expression in Murine Pancreatic β Cells through ERK/JNK-AP1 and NF-κB Related Signaling Pathways Independent of CCR2

  2011cited by this paper
• Heterogeneous amylin fibril growth mechanisms imaged by total internal reflection fluorescence microscopy.

  2011cited by this paper
• Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.

  2011cited by this paper
• cJUN N-terminal kinase (JNK) activation mediates islet amyloid-induced beta cell apoptosis in cultured human islet amyloid polypeptide transgenic mouse islets

  2011cited by this paper
• Coffee components inhibit amyloid formation of human islet amyloid polypeptide in vitro: possible link between coffee consumption and diabetes mellitus.

  2011cited by this paper
• TNF-α acutely upregulates amylin expression in murine pancreatic beta cells

  2011cited by this paper
• Mechanism of Amylin Fibrillization Enhancement by Heparin*

  2011cited by this paper
• 2DIR spectroscopy of human amylin fibrils reflects stable β-sheet structure.

  2011cited by this paper
• Fibril Structure of Human Islet Amyloid Polypeptide*♦

  2011cited by this paper
• Biphasic effects of insulin on islet amyloid polypeptide membrane disruption.

  2011cited by this paper
• Resveratrol inhibits the formation of multiple-layered β-sheet oligomers of the human islet amyloid polypeptide segment 22-27.

  2011cited by this paper
• Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence?

  2010cited by this paper
• Combination of kinetically selected inhibitors in trans leads to highly effective inhibition of amyloid formation.

  2010cited by this paper
• The effect of curcumin on human islet amyloid polypeptide misfolding and toxicity

  2010cited by this paper
• Inhibition of IAPP and IAPP(20-29) fibrillation by polymeric nanoparticles.

  2010cited by this paper
• The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity.

  2010cited by this paper
• Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin.

  2010cited by this paper

• Deuterium trafficking, mitochondrial dysfunction, copper homeostasis, and neurodegenerative disease

  2025cites this paper
• Differential Modulation of Copper(II) Interactions with the 18–22 Coordinating Amylin Fragment by the Geometric Isomers of a New Nicotinoyl Hydrazone: A First Study

  2025cites this paper
• Exploring the intricacies of protein-nanoparticle interaction and its implications in chronic diseases: a comprehensive review.

  2025cites this paper
• Faster Amylin Aggregation on Fibrillar Collagen I Hastens Diabetic Progression through β-Cell Death and Loss of Function.

  2025cites this paper
• AuNPs synthesised in situ from self-assembled peptide hydrogels modulating peptide secondary structure

  2025cites this paper
• Matching model with mechanism: Appropriate rodent models for studying various aspects of diabetes pathophysiology.

  2025cites this paper
• Transition State Conformations for IDPs: Application to Human Amylin (hIAPP).

  2025cites this paper
• Diffusing protein binders to intrinsically disordered proteins

  2025influential citation
• Amyloid fibril cytotoxicity and associated disorders.

  2024cites this paper
• Mitigating diabetes associated with reactive oxygen species (ROS) and protein aggregation through pharmacological interventions

  2024cites this paper
• Effect of Histidine Behaviors on Structural Properties of Human Islet Amyloid Peptides

  2024cites this paper
• Peel waste of citrus fruits: A valuable and renewable source of polyphenols for the treatment of diabesity

  2024cites this paper
• Application of carbon dots-based nanomaterials in amyloid aggregation disease

  2024cites this paper
• Cross-domain binding of anti-fibrillation peptide TNGQ to islet amyloid polypeptide provides cytoprotective effects in giant unilamellar vesicles and pancreatic β-cells.

  2024cites this paper
• In-silico analysis of islet amyloid polypeptide (IAPP) to predict the potential mutations involved in type II diabetes

  2024cites this paper
• Structure prediction and refinement of protein sequence to identify intrinsically disordered regions of islet amyloid polypeptide (IAPP) using in-silico approach

  2024cites this paper
• Identification of novel ligands for inhibition of mutant Q43R islet amyloid polypeptide (IAPP) using In-silico docking

  2024cites this paper
• Unraveling the Molecular Jam: How Crowding Shapes Protein Aggregation in Neurodegenerative Disorders.

  2024cites this paper
• Drugging Disordered Proteins by Conformational Selection to Inform Therapeutic Intervention

  2024cites this paper
• Novel Hominid-Specific IAPP Isoforms: Potential Biomarkers of Early Alzheimer’s Disease and Inhibitors of Amyloid Formation

  2023cites this paper
• The Effect of Calcium Ions on hIAPP Channel Activity: Possible Implications in T2DM

  2023cites this paper
• Islet amyloid polypeptide tagged with green fluorescent protein localises to mitochondria and forms filamentous aggregates in Caenorhabditis elegans

  2023cites this paper
• Interspecies Variation Affects IAPP Membrane Binding

  2023cites this paper
• Phytoconstituents of Ashwagandha as potential inhibitors of human islet amyloid polypeptide (hIAPP): an in silico investigation

  2023cites this paper
• Realization of Amyloid-like Aggregation as a Common Cause for Pathogenesis in Diseases

  2023cites this paper
• The Metabolostasis Network and the Cellular Depository of Aggregation-Prone Metabolites.

  2023cites this paper
• Interspecies Variation Affects Islet Amyloid Polypeptide Membrane Binding.

  2023cites this paper
• The Role of Heme and Copper in Alzheimer’s Disease and Type 2 Diabetes Mellitus

  2023cites this paper
• Treatment with semaglutide, a GLP-1 receptor agonist, improves extracellular matrix remodeling in the pancreatic islet of diet-induced obese mice.

  2023cites this paper
• Intercommunication between metal ions and amyloidogenic peptides or proteins in protein misfolding disorders

  2023cites this paper
• An environmentally sensitive molecular rotor as a NIR fluorescent probe for the detection of islet amyloid polypeptide.

  2022cites this paper
• Therapeutic potential of Nigella sativa in the prevention of aggregation and glycation of proteins

  2022cites this paper
• Thermodynamic surprises of Cu(II)–amylin analogue complexes in membrane mimicking solutions

  2022cites this paper
• Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer’s disease

  2022cites this paper
• Disaggregation of Islet Amyloid Polypeptide Fibrils as a Potential Anti-Fibrillation Mechanism of Tetrapeptide TNGQ

  2022cites this paper
• Clinicopathologic characteristics of pancreatic islet amyloidosis in the rhesus macaque (Macaca mulatta) and sooty mangabey (Cercocebus atys)

  2022cites this paper
• Influencing factors and characterization methods of nanoparticles regulating amyloid aggregation.

  2022cites this paper
• Upregulation of GLUT4 and PI3K, and downregulation of GSK3 mediate the anti-hyperglycemic effects of proanthocyanidins

  2022cites this paper
• Linking hIAPP misfolding and aggregation with type 2 diabetes mellitus: a structural perspective

  2022cites this paper
• Decoration of modified self‐assembly membrane by magnesium oxide and yttrium oxide nanoparticles for biosensors, supercapacitors, and water treatment

  2022cites this paper
• Recent Advances in the Discovery of Therapeutics to Curtail Islet Amyloid Polypeptide Aggregation for Type 2 Diabetes Treatment

  2022cites this paper
• Evidence of the different effect of mercury and cadmium on the hIAPP aggregation process.

  2022cites this paper
• Human Islet Amyloid Polypeptide (hIAPP) Protofibril‐Specific Antibodies for Detection and Treatment of Type 2 Diabetes

  2022cites this paper
• The Alterations and Roles of Glycosaminoglycans in Human Diseases

  2022cites this paper
• Association of Islet Amyloid Polypeptide to C-Peptide Ratio With Cystic Fibrosis–Related Diabetes

  2022cites this paper
• Type 2 Diabetes, Obesity, and Cancer Share Some Common and Critical Pathways

  2021cites this paper
• Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy

  2021cites this paper
• Targeting disorders in unstructured and structured proteins in various diseases.

  2021cites this paper
• Thermodynamic Surprises of Cu(II)-Amylin Complexes in Membrane Mimicking Solutions

  2021cites this paper
• Urolithins: Diet-Derived Bioavailable Metabolites to Tackle Diabetes

  2021cites this paper
• Molecular simulations of IDPs: From ensemble generation to IDP interactions leading to disorder-to-order transitions.

  2021cites this paper
• Rice Compounds with Impact on Diabetes Control

  2021cites this paper
• Cryo-EM structures of hIAPP fibrils seeded by patient-extracted fibrils reveal new polymorphs and conserved fibril cores

  2021cites this paper
• Exploring the Propensities of Fluorescent Carbazole Analogs toward the Inhibition of Amyloid Aggregation in Type 2 Diabetes: An Experimental and Theoretical Endeavor.

  2021cites this paper
• Innate immunity in diabetes mellitus

  2021cites this paper
• Nonhuman IAPP Variants Inhibit Human IAPP Aggregation.

  2021cites this paper
• Optimized experimental pre-treatment strategy for temporary inhibition of islet amyloid polypeptide aggregation

  2021cites this paper
• The Plasticity of Pancreatic β-Cells

  2021cites this paper
• Curcumin: A small molecule with big functionality against amyloid aggregation in neurodegenerative diseases and type 2 diabetes

  2021influential citation
• Triggering of intracellular aggregation and cytotoxicity by immature forms of human Islet Amyloid Polypeptide

  2021influential citation
• Peptide–Protein Interactions: From Drug Design to Supramolecular Biomaterials

  2021cites this paper
• Disaggregation mechanism of prion amyloid for tweezer inhibitor.

  2021cites this paper
• Triterpenoids impede the fibrillation and cytotoxicity of human islet amyloid polypeptide.

  2021cites this paper
• Synthesis of Yakuchinone B-Inspired Inhibitors against Islet Amyloid Polypeptide Aggregation.

  2021cites this paper
• Fluorescence-based techniques for the detection of the oligomeric status of proteins: implication in amyloidogenic diseases

  2021cites this paper
• The Human Islet Amyloid Polypeptide in Protein Misfolding Disorders: Mechanisms of Aggregation and Interaction with Biomembranes.

  2020cites this paper
• Development of Novel PET Imaging Probes for Detection of Amylin Aggregates in the Pancreas.

  2020cites this paper
• The impact of chemical engineering and technological advances on managing diabetes: present and future concepts.

  2020cites this paper
• Tyrosine carbon dots inhibit fibrillation and toxicity of the human islet amyloid polypeptide

  2020cites this paper
• Insights from nature: A review of natural compounds that target protein misfolding in vivo

  2020cites this paper
• Sodium‐glucose co‐transporters and diabetic nephropathy: Is there a link with toll‐like receptors?

  2020cites this paper
• Role of lysine residue of islet amyloid polypeptide in fibril formation, membrane binding, and inhibitor binding.

  2020cites this paper
• Date palm (Phoenix dactylifera L.) fruit's polyphenols as potential inhibitors for human amylin fibril formation and toxicity in type 2 diabetes.

  2020cites this paper
• Inhibition of human islet amyloid polypeptide aggregation and cellular toxicity by oleuropein and derivatives from olive oil.

  2020cites this paper
• Islet Amyloid Polypeptide

  2020cites this paper
• Link between Diabetes and Alzheimer’s Disease Due to the Shared Amyloid Aggregation and Deposition Involving Both Neurodegenerative Changes and Neurovascular Damages

  2020cites this paper
• Human islet amyloid polypeptide (hIAPP) aggregation in type 2 diabetes: Correlation between intrinsic physicochemical properties of hIAPP aggregates and their cytotoxicity.

  2019cites this paper
• Perspectives on drug discovery strategies based on IDPs

  2019cites this paper
• Bioanalysis using capillary electrophoresis and mass spectrometry : Applied on proteins, protein nanofibrils and polyvinyl alcohol microbubbles

  2019cites this paper
• The flanking peptides issue from the maturation of the human islet amyloid polypeptide (hIAPP) slightly modulate hIAPP-fibril formation but not hIAPP-induced cell death.

  2019cites this paper
• Synthesis and evaluation of novel two-photon fluorescence probes for in vivo imaging of amylin aggregates in the pancreas

  2019cites this paper
• Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations

  2019cites this paper
• Effects of lithospermic acid on hIAPP aggregation and amyloid-induced cytotoxicity by multiple analytical methods.

  2019cites this paper
• Altered metabolic gene expression in the brain of a triprolyl-human amylin transgenic mouse model of type 2 diabetes

  2019cites this paper
• Targeting the Intrinsically Disordered Proteome Using Small-Molecule Ligands.

  2018cites this paper
• Evaluating effectiveness of a Continuous Glucose Monitoring System (CGMS) in diabetic dogs and cats

  2018cites this paper
• E�cient optical plasmonic tweezer-controlled single-molecule SERS characterization of pH-dependent amylin species in aqueous milieus

  year unknowncites this paper